NORVAXIS Ventures
Backing Founders Who Build What's Next
NORVAXIS Ventures is the early-stage investment arm of NORVAXIS Holdings. We partner with exceptional founders at the pre-seed and seed stage — bringing capital, conviction, and a network built over two decades.
Investment Thesis
We Back Outliers, Not Consensus
Most early-stage capital chases the same ideas in the same sectors. We go where the signal is weak but the opportunity is large — contrarian bets on founders with deep domain expertise, unconventional approaches, and the resilience to build through uncertainty.
Domain-First Founders
We prioritize founders who have spent years inside a problem — operators, scientists, and builders who understand their market from the inside out.
Defensible Differentiation
We look for structural advantages: proprietary data, network effects, regulatory moats, or technology that is genuinely hard to replicate.
Global Ambition
We back companies built to operate across borders from day one — not regional plays that hope to expand later.
Long-Term Alignment
We take concentrated positions and hold them. We are not optimizing for a quick flip — we want to be your partner through every stage of growth.
Focus Areas
Where We Invest
AI & Data Infrastructure
Foundation models, enterprise AI tooling, data pipelines, and the infrastructure layer that makes AI deployable at scale.
Climate & Energy Transition
Technologies accelerating decarbonization — grid software, industrial electrification, carbon markets, and next-generation energy storage.
Healthcare & Biotech
Diagnostics, precision medicine, digital health platforms, and tools that reduce cost and improve outcomes across the care continuum.
Financial Infrastructure
B2B fintech, embedded finance, alternative credit, and the plumbing that powers modern financial services.
Defense & Dual-Use Tech
Autonomous systems, cybersecurity, satellite infrastructure, and technologies with both commercial and national security applications.
Future of Work
Platforms reshaping how knowledge workers collaborate, learn, and create — with a focus on productivity multipliers, not replacements.
What to Expect
How We Work With Founders
Check Size
$250K – $2M
Stage
Pre-Seed & Seed
Geography
Global (US, Europe, MENA)
Decision Timeline
2–4 weeks
Board Involvement
Observer or Board Seat
Follow-On
Active in subsequent rounds
Submit a Pitch
Tell Us About Your Company
We review every submission. If there is a fit, we will reach out within two weeks. We do not require a warm introduction.
Submissions are reviewed on a rolling basis. NORVAXIS Ventures does not provide feedback on unsolicited pitches. All information is kept strictly confidential.